A Compartive Study of Dengue Verses Malaria in Tertiary Care Hospital versus Government Hospital
In an attempt we are assessing a clinical study, knowledge, awareness and preventive measures acknowledgment of Communicable Diseases such as Dengue and Malaria among patients in Tertiary Care Hospital Versus Government Hospital in Khammam, to compare the probability of communicable disease such as Dengue and Malaria in selected Hospital. To compare the prevalence of Dengue and Malaria among Urban and Rural people in selected hospitals. The present study was a multi-cantered prospective observational study conducted in Mamatha General Hospital and Khammam Government Hospital, Khammam, Telangana, India. The total number of cases collected during the study period 6 months was 500. A multi-centered prospective observational study. The major finding of this study is that the probability of Communicable diseases such as Malaria and Dengue among patients. In this study the population is 500, the highest Prevalence is Dengue i.e. 465(93%) than Malaria i.e. 35(7%). In these Female patients are high i.e. 252 compared to Male i.e. 248. According to study evaluation females are more affected. The occurrence of Dengue is observed in the Age group of 41-50 years i.e. 90 patients. The Rural group related patients i.e. 342 are more when compared to urban group related patients i.e. 158. The present multi-centered prospective observational study was conducted in subjects(n=500) from inpatients of Department of General Medicine, Mamatha General Hospital and Khammam Government Hospital, Khammam, Telangana, India, to assess the Probability of Malaria and Dengue, Knowledge assessment among patients about Malaria and Dengue, and also Acknowledging the patients about Dengue and Malaria.
2. Patz, J.A., et al., Effects of environmental change on emerging parasitic diseases. Int J Parasitol, 30(12-13): p. 1395 – 405 (2000).
3. Council for International organizations of Medical Sciences. Communicable Diseases, Provisional International Nomenclature. Geneva: World Health Organization: 1973.
4. Noji E, editor. Public health consequences of disasters. New York : Oxford University Press; 1997.
5. Qadri F, Khan AI, Faruque ASG, et al. Entero-toxigenic Escherichia coli and Vibrio cholera diarrhea, Bangladesh. Emerging Infectious Diseases. 2005; 11:1104-7.
6. World Health Organization. Acute jaundice syndrome. Weekly Mortality and Morbidity Report. 2006; 23:8.
7. Lifson AR. Mosquitoes, models, and dengue. Lancet. 1996; 347 : 1201 – 2.
8. World Health Organization. International Health Regulations. 2005.;
9. https:// Harrison-principles-internal-medicine-19th edition.
10. WHO. Dengue and dengue haemorrhagic fever. Factsheet N˚ 117, revised May 2008. Geneva, World Health Organization, 2008 (http: // www.who.int/mediacentre/ factsheets/fs 117/en/).
11. http:// www.who.int/gb/ebwha/WHA55/ewha5517.
12. Leitmeyer KC. Dengue virus structural differences that correlate with pathogenesis. Journal of Virology, 1999, 73(6) : 4738-4747.
13. lanciotti RS et al. Molecular evolution and epidemiology of dengue – 3 viruses. Journal of General Virology, 1994, 75 (Pt 1): 65-75.
14. Messer WB. Emergence and global spread of dengue serotype 3, subtype III virus. Emerging Infectious Diseases, 2003, 9(7) : 800-809.
15. Halstead SB . Patho-physiology and pathogenesis of dengue haemorrhagic fever. In: Thongchareon P, ed, Monograph on dengue/ dengue haemorrhagic fever.
16. Halstead SB. Antibody, Macrophages, dengue virus infection, shock, and hemorrhage : a pathogenic cascade. Reviews of Infectious Diseases.
17. Halstead SB, Heinz FX. Dengue virus : molecular basis of cell entry and pathogenesis,25-27 June 2003, Vienna, Austria. Vaccine, 2005, 23(7) : 849 – 856.
18. Kouri GP, Guzman MG. Race : a risk factor for dengue hemorrhagic fever. Archives of Virology, 2006, 152(3); 533-542.
23. Achee N. L., et al., in 2015. A critical assessment of vector control for dengue prevetion.
25. C.K. Murray, R. A. Gasser Jr., A. J. Magill, and R. S. Miller, “Update on rapid diagnostic testing for malaria,” Clinical Microbiology Reviews.
26. Macro A. Biamonte, et al., Recent Advances in Malaria Drug Discovery.
29. World Health Organization. International Health Regulations, 2008;
30. World health Organization. SARS: lessons from a new disease, in the World Health Report 2003. http://www.who.int/whr/2003/en.pdf.
31. Murray NEA, Quam MB, Wider –Smith A. Epidemiology of dengue: past, present, future prospects.
32. Guzman MG, Kouri G. Dengue : an update. Lancet, Infect Dis. 2002;2(1).
37. sharma MK, et al., Surveillance of Communicable disease at a tertiary care hospital a tool for planning.
39. Sharma AK, Bhasin S, Chaturvedi S. Predictors of Knowledge about malaria in India. J Vector Borne Disease.
40. Kohli C, Kumar R, et al., A study on Knowledge and Preventive Practices about Mosquito Borne Diseases in Delhi. J MAMC Medical Sciences.
41. Mlahotra G, Yadav A, Knowledge, awareness and practice regarding dengue among rural and slum communities.
42. Kessels PJ, et al., Knowledge and use of prevention measures related to dengue in North Thailand.
43. World Health Organization (WHO) Global Strategy for Dengue Prevention and Control, 2012-2020.
44. Syed M, et al., Knowledge, attitudes and practices regarding dengue fever among adults of high and low socioeconomic groups.
45. CDC, Centers for Disease Control and Prevention. Dengue fever. Colorado: 2008.
47. http://www.who.int/mediacentre /factsheetx/fs 117/en/
48. WHO. Guidelines for the treatment of malaria. 2nd ed. Geneva World Health
49. WHO. Malaria rapid diagnostic test performance: results of WHO product testing of malaria RDTs round 6. Geneva: World Health Organization; 2015.
51. http: // www.who.int/csr/disease/dengue/impact/en/.
Copyright © Author(s) retain the copyright of this article.